REQUEST A DEMO
Total
USD $0.00
Search more companies

Farma Rysanek A.S. (Czech Republic)

Main Activities: Real Estate
Full name: Farma Rysanek A.S. Profile Updated: September 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Farma Rysanek A.S. is a company in Czech Republic, with a head office in Prague. The company operates in the Real Estate industry. It was established on November 18, 2019. It currently has a total number of 1 - 5 (2023) employees. In 2022, the company reported a net sales revenue drop of 54.82%. During that time, Farma Rysanek A.S.’s total assets decreased by 45.83%. The enterprise’s net profit margin increased by 17.06% in 2022.

Headquarters
Antala Staska 1859/34
Prague; The City of Prague; Postal Code: 14000

Contact Details: Purchase the Farma Rysanek A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Farma Rysanek A.S. report to view the information.
Outstanding Shares:
Purchase the Farma Rysanek A.S. report to view the information.
Registered Capital:
Purchase the Farma Rysanek A.S. report to view the information.
Incorporation Date:
November 18, 2019
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Farma Rysanek A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-54.82%
Total operating revenue
-54.82%
Operating profit (EBIT)
-22.01%
Net Profit (Loss) for the Period
-14.92%
Total assets
-45.83%
Total equity
80.01%
Operating Profit Margin (ROS)
19.33%
Net Profit Margin
17.06%
Return on Equity (ROE)
-49.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?